High-Dose Anemia Drugs Linked To Increased Cancer Risk Among Dialysis Patients Study Suggests
Managing anemia is a critical part of care for patients with chronic kidney disease (CKD), especially those undergoing dialysis. For years, erythropoiesis-stimulating agents (ESAs) have played an important role in helping raise hemoglobin levels and reduce the need for blood transfusions. However, new research is raising an important clinical question: could higher-dose ESA use be […]







